Clinical Study on ShouTai Pills for Improving Reduced Ovarian Reserve

Starting soon · Not applicable · Has a placebo group

Conditions studied: Diminished Ovarian Reserve (DOR)

In brief

Grounded in the 'disease-syndrome combination' paradigm, this study endeavors to address the pivotal scientific issues pertaining to the clinical precision of Traditional Chinese Medicine (TCM) in managing Diminished Ovarian Reserve (DOR) classified as the Kidney Essence Deficiency type, through the application of systems biology technologies, including metabolomics.

Key facts

Study ID

NCT07737847

Run by

Peking Union Medical College Hospital

People needed

136

Starts

2026-10-01

Expected to finish

2028-12-31

Last updated by the study team

2026-07-30

Who can join

Age: 20 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• The inclusion criteria are as follows: ① meeting the above-mentioned integrated Chinese and Western medicine diagnostic criteria for DOR
• ② no use of estrogen-containing medications within the past 1 month
• ③ patients scheduled to undergo IVF-ET
• ④ provision of signed informed consent, voluntary participation, and good compliance.

You may not qualify if…

• The exclusion criteria are as follows: ① patients with polycystic ovary syndrome (PCOS) or stage III/IV endometriosis
• ② uterine conditions including untreated submucous myomas, intramural myomas >4 cm in diameter, intrauterine adhesions, uterine septum, or other uterine anomalies
• ③ couples undergoing preimplantation genetic diagnosis (PGD) for genetic reasons
• ④ body mass index (BMI) ≥28 kg/m²
• ⑤ history of prior pelvic radiotherapy or cytotoxic chemotherapy
• ⑥ significant systemic diseases, such as uncontrolled hypertension, diabetes mellitus, thyroid dysfunction, hepatic or renal insufficiency, cardiac disorders, or autoimmune diseases
• ⑦ use of medications that may interfere with this study within the past 1 month, including but not limited to estrogens, hepatic enzyme modulators, and agents that may affect the endocrine system (hormonal drugs)
• ⑧ known allergy to any components of the study medication
• and ⑨ participation in another drug trial within the past 3 months. -

Where it is running

• Peking Union Medical College Hospital — Beijing, Beijing Municipality, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.